Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 CAZ-AVI vs doripenem in complicated urinary tract infections
jRCT2080221955Phase 3
- Sponsor
- AstraZeneca
- Start
- Nov 2012
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ceftazidime + avibactam in complicated urinary tract infection (cUTI) and acute pyelonephritis (2 arms), sponsored by AstraZeneca.
02
Drugs
ceftazidime + avibactam
03
Conditions
complicated urinary tract infection (cUTI)acute pyelonephritis
Beyond the preview
Go deeper on jRCT2080221955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221955.